CXCR5 and melanoma: These findings should now be further investigated in the CXCR5 CD4+ subtypes, which can also be subcategorized into Th17, Th1, and Th2, including clonality and melanoma-specificity in the TME and periphery, since these subpopulations are often affected as side targets [19].